Updated findings from a phase 2 study investigating the IL-2–binding monoclonal antibody AU-007 show a manageable safety ...

Researchers from the Sant Pau Research Institute (IR Sant Pau), in collaboration with Sant Pau Hospital and the Josep Carreras Leukaemia Research Institute, have developed an innovative CAR-T cell ...

Aulostm Bioscience, an immuno-oncology company working to revolutionize cancer care through development of its lead immune-activating antibody therapeutic, today presented positive results from its ...

Pancreatic cancer patient (MSI-H) achieved a durable response for 20 months during the study with complete resolution of target and non-target metastatic lesions in the liver including a new lesion ...

A ready-made version of a cutting-edge cancer immunotherapy can effectively defeat blood cancers, a new study says.

The study’s small size limits interpretation, but it remains the largest real-world data available, experts said.

Webcast and replay information for this event will also be available on the Investor Relations section of Medicenna's website at ir.medicenna.com. The replay will be available for 90 days. The Bloom ...

The antibody harnesses the power of interleukin-2 (IL-2) by binding precisely to the portion of IL-2 that binds to CD25, which prevents IL-2 from binding to high-affinity IL-2 receptors on Tregs, ...

You may need additional care if you have type 2 diabetes during pregnancy. But it’s possible to have a healthy pregnancy and delivery if you have type 2 diabetes. If you have type 2 diabetes ...

Using the best PvE weapons makes beating Destiny 2’s most challenging content much easier. To help you overcome what lies ahead, you’ll want to be using these recommended meta guns in Episode ...

From supplements to guided meditation, your diabetes treatment could include traditional medicines, alternative therapies, and natural remedies, too. The National Center for Complementary and ...